title: Obesity and cholangiocarcinoma.
abstract: It is estimated that about half of the population in developed countries are either overweight or obese. In some developing nations obesity rates have increased to surpass those seen in Western countries. This rate increase in obesity has many implications as obesity has been associated with numerous negative health effects including increased risks of hypertension, diabetes, cardiovascular disease, stroke, liver disease, apnea, and some cancer types. Obesity is now considered to be one of the major public health concerns facing the society. Cholangiocarcinomas (bile duct cancers) are malignant tumors arising from cholangiocytes inside or outside of the liver. Although cholangiocarcinomas are relatively rare, they are highly lethal. The low survival rate associated with cholangiocarcinoma is due to the advanced stage of the disease at the time of diagnosis. Prevention is therefore especially important in this cancer type. Some data suggest that the incidence of cholangiocarcinoma in the western world is on the rise. Increasing rate of obesity may be one of the factors responsible for this increase. Determining whether obesity is a risk factor for cholangiocarcinoma has significant clinical and societal implications as obesity is both prevalent and modifiable. This paper seeks to provide a summary of the current knowledge linking obesity and cholangiocarcinoma, and encourage further research on this topic.
authors: Center for Endoscopy and Pancreatobiliary Disorders, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA. parsim@ccf.org
authors: Mansour A
authors: MA
authors: Parsi
mesh_terms: D001650:Bile Duct Neoplasms / Q000453:epidemiology*; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D009765:Obesity / Q000453:epidemiology*; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors
keywords: Bile ducts; Cancer; Cholangiocarcinoma; Epidemiology; Obesity
references: Lancet. 2011 Feb 12;377(9765):557-67
references: 21295846
references: Parasitol Int. 2012 Mar;61(1):173-7
references: 21855650
references: Cancer Sci. 2010 Mar;101(3):579-85
references: 20085587
references: Med Oncol. 2011 Dec;28(4):1288-95
references: 20625941
references: Nat Rev Cancer. 2011 Nov 24;11(12):886-95
references: 22113164
references: J Clin Invest. 2003 Dec;112(12):1796-808
references: 14679176
references: Anthropol Anz. 2009 Jun;67(2):205-12
references: 19739469
references: Gut. 2006 Feb;55(2):285-91
references: 16239255
references: Asia Pac J Clin Nutr. 2011;20(1):35-41
references: 21393108
references: Gastroenterol Clin North Am. 2010 Mar;39(1):1-7
references: 20202574
references: Obes Rev. 2010 May;11(5):335-7
references: 20202133
references: Asia Pac J Clin Nutr. 2006;15 Suppl:3-14
references: 16928656
references: Diabetes Metab. 2012 Nov;38(5):404-11
references: 22626474
references: Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8
references: 17689296
references: JAMA. 2010 Jan 20;303(3):235-41
references: 20071471
references: MMWR Morb Mortal Wkly Rep. 2010 Aug 6;59(30):951-5
references: 20689500
references: N Z Med J. 2010 Mar 19;123(1311):30-42
references: 20360794
references: Expert Opin Investig Drugs. 2006 Aug;15(8):917-31
references: 16859394
references: Hepatology. 2001 Jun;33(6):1353-7
references: 11391522
references: Int J Hepatol. 2012;2012:630543
references: 21994887
references: Dig Liver Dis. 2010 Apr;42(4):253-60
references: 20097142
references: Obes Rev. 2012 Mar;13(3):287-96
references: 22034908
references: J Clin Oncol. 2005 Jul 20;23(21):4742-54
references: 16034050
references: Int J Cancer. 2007 Feb 1;120(3):638-41
references: 17109384
references: Acta Trop. 2011 Sep;120 Suppl 1:S158-68
references: 20655862
references: Gastroenterology Res. 2009 Jun;2(3):132-140
references: 27933122
references: Lancet. 2008 Feb 16;371(9612):536-7
references: 18280312
references: J Gastroenterol Hepatol. 1994 Sep-Oct;9(5):462-7
references: 7827297
references: Br J Cancer. 2007 Oct 8;97(7):1005-8
references: 17700568
references: Lancet. 2008 Feb 16;371(9612):569-78
references: 18280327
references: J Natl Cancer Inst. 2006 Jun 21;98(12):873-5
references: 16788161
references: Rev Saude Publica. 2009 Nov;43 Suppl 2:83-9
references: 19936502
references: Hormones (Athens). 2010 Jul-Sep;9(3):253-62
references: 20688623
references: Endocr Rev. 2012 Feb;33(1):48-70
references: 22240243
references: Anticancer Agents Med Chem. 2011 Jun;11(5):470-8
references: 21492072
references: J Am Coll Surg. 2008 Oct;207(4):594-603
references: 18926465
references: Cancer Metastasis Rev. 2010 Dec;29(4):641-53
references: 20821253
references: Nat Clin Pract Gastroenterol Hepatol. 2006 Jan;3(1):33-42
references: 16397610
references: NCHS Data Brief. 2012 Jan;(82):1-8
references: 22617494
references: Oncology (Williston Park). 2011 Oct;25(11):994-1000
references: 22106549
references: Best Pract Res Clin Anaesthesiol. 2011 Mar;25(1):1-9
references: 21516909
references: J Clin Invest. 2001 Oct;108(8):1113-21
references: 11602618
references: World J Gastrointest Oncol. 2010 Nov 15;2(11):407-16
references: 21160904
references: Endocr Relat Cancer. 2007 Sep;14(3):669-77
references: 17914097
references: Curr Gastroenterol Rep. 2011 Apr;13(2):182-7
references: 21271364
references: Menopause Int. 2008 Mar;14(1):33-7
references: 18380959
references: Eur J Cancer. 2009 Nov;45(16):2867-73
references: 19427197
references: JAMA. 2012 Feb 1;307(5):491-7
references: 22253363
references: J Gastrointestin Liver Dis. 2010 Sep;19(3):285-90
references: 20922193
references: PLoS One. 2011;6(11):e27455
references: 22102897
references: J Hepatol. 2006 Jun;44(6):1055-65
references: 16469407
references: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78
references: 19755644
references: Cancer Res. 2008 Aug 15;68(16):6752-61
references: 18701500
references: Br J Cancer. 2009 Jan 13;100(1):178-80
references: 19018260
references: Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1531-43
references: 12496040
references: Am J Physiol Endocrinol Metab. 2011 Oct;301(4):E567-84
references: 21791620
references: Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):14-22
references: 21157323
references: Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):471-8
references: 19640194
references: Surg Oncol Clin N Am. 2009 Jul;18(3):439-52
references: 19500735
references: Curr Opin Gastroenterol. 2008 May;24(3):349-56
references: 18408464
references: Am J Pathol. 2006 Apr;168(4):1155-68
references: 16565491
references: Semin Liver Dis. 2004 May;24(2):115-25
references: 15192785
references: J Biol Chem. 2003 Nov 28;278(48):47585-93
references: 12975378
references: J Hepatol. 2012 Apr;56(4):848-54
references: 22173164
references: Lancet. 2011 Aug 27;378(9793):804-14
references: 21872749
references: Hepatology. 2008 Jul;48(1):308-21
references: 18536057
references: Cancer Lett. 2005 Mar 10;219(2):205-13
references: 15723721
references: Cell. 2010 Mar 19;140(6):883-99
references: 20303878
references: Vet J. 2005 Sep;170(2):264-7
references: 16129347
references: J Natl Cancer Inst. 2011 Feb 2;103(3):250-63
references: 21191117
references: Hepatology. 2005 Jan;41(1):5-15
references: 15690474
references: HPB (Oxford). 2008;10(2):77-82
references: 18773060
references: Hepatogastroenterology. 1998 May-Jun;45(21):665-71
references: 9684114
references: Am J Clin Nutr. 2007 Sep;86(3):556-65
references: 17823417
references: Hepatology. 2011 Jul;54(1):173-84
references: 21488076
references: Eur J Cancer Prev. 2012 Mar;21(2):126-33
references: 21960184